Helen of Troy Limited (HELE) Income Statement

30Y historyFree accessUpdated daily

Revenue growth returned in 2027Q1 (+8.2%) and 2027Q2 (+2.1%) after eight consecutive declines, but the 52.2% gross margin failed to translate to the bottom line as SG&A of $204.7M compressed operating margin to just 5.2% in 2027Q2.

Annual statement

HELE Income Statement

Helen of Troy Limited (HELE) annual income statement — 30-year revenue, gross profit & net income history

Annual Quarterly

Metric	TTM	Feb'26	Feb'25	Feb'24	Feb'23	Feb'22	Feb'21	Feb'20	Feb'19	Feb'18	Feb'17	Feb'16	Feb'15	Feb'14	Feb'13	Feb'12	Feb'11	Feb'10	Feb'09	Feb'08	Feb'07	Feb'06	Feb'05	Feb'04	Feb'03	Feb'02	Feb'01	Feb'00	Feb'99	Feb'98	Feb'97

Sales/Revenue	1.83B	1.79B	1.91B	2.01B	2.07B	2.22B	2.1B	1.71B	1.56B	1.48B	1.4B	1.39B	1.45B	1.32B	1.29B	1.18B	777.04M	647.63M	622.75M	652.55M	634.93M	589.75M	581.55M	474.87M	458.82M	451.25M	361.4M	299.51M	294.5M	248.1M	213M
Revenue Growth %	0.32%	-6.36%	-4.86%	-3.26%	-6.78%	5.93%	22.92%	9.16%	5.77%	5.82%	0.36%	-3.64%	9.72%	2.24%	9.02%	52.07%	19.98%	4%	-4.57%	2.77%	7.66%	1.41%	22.47%	3.5%	1.68%	24.86%	20.66%	1.7%	18.7%	16.48%	27.47%
Cost of Goods Sold	960.91M	970.6M	993.26M	1.06B	1.17B	1.27B	1.17B	972.97M	923.04M	867.65M	824.12M	866.84M	845.57M	800.45M	770.05M	703.19M	427.8M	368.47M	367.34M	370.85M	355.55M	323.19M	307.05M	257.65M	247.79M	238.86M	212.39M	178.76M	170.3M	149.1M	130.2M
COGS % of Revenue	-	54.34%	52.07%	52.69%	56.61%	57.13%	55.82%	56.98%	59.01%	58.67%	58.97%	62.25%	58.51%	60.77%	59.77%	59.51%	55.05%	56.9%	58.99%	56.83%	56%	54.8%	52.8%	54.26%	54.01%	52.93%	58.77%	59.68%	57.83%	60.1%	61.13%
Gross Profit	864.98M	815.69M	914.41M	948.66M	899.35M	953.19M	927.3M	734.47M	641.11M	611.2M	573.42M	525.73M	599.56M	516.7M	518.21M	478.48M	349.25M	279.16M	255.4M	281.69M	279.38M	266.56M	274.5M	217.22M	211.03M	212.39M	149M	120.75M	124.2M	99M	82.8M
Gross Margin %	47.37%	45.66%	47.93%	47.31%	43.39%	42.87%	44.18%	43.02%	40.99%	41.33%	41.03%	37.75%	41.49%	39.23%	40.23%	40.49%	44.95%	43.1%	41.01%	43.17%	44%	45.2%	47.2%	45.74%	45.99%	47.07%	41.23%	40.32%	42.17%	39.9%	38.87%
Gross Profit Growth %	-	-10.8%	-3.61%	5.48%	-5.65%	2.79%	26.26%	14.56%	4.89%	6.59%	9.07%	-12.31%	16.04%	-0.29%	8.3%	37%	25.11%	9.3%	-9.33%	0.83%	4.81%	-2.89%	26.37%	2.93%	-0.64%	42.54%	23.4%	-2.78%	25.45%	19.57%	23.58%
Operating Expenses	761.86M	708.91M	771.66M	688.07M	687.56M	680.64M	645.81M	556.22M	441.73M	442.14M	403.75M	409.44M	437.84M	399.6M	369.42M	339.1M	235.34M	188.89M	188.34M	207.77M	208.96M	195.18M	172.48M	131.44M	158.17M	170.73M	118.31M	111.33M	87.9M	68.9M	60.1M
OpEx % of Revenue	-	39.69%	40.45%	34.32%	33.17%	30.61%	30.77%	32.58%	28.24%	29.9%	28.89%	29.4%	30.3%	30.34%	28.68%	28.7%	30.29%	29.17%	30.24%	31.84%	32.91%	33.1%	29.66%	27.68%	34.47%	37.84%	32.74%	37.17%	29.85%	27.77%	28.22%
Selling, General & Admin	693.41M	708.91M	622.65M	621.74M	595.9M	611.03M	569.71M	484.5M	414.84M	374.58M	356.46M	368.01M	428.84M	369.33M	369.44M	339.1M	235.34M	188.89M	188.34M	207.77M	208.96M	195.18M	172.48M	131.44M	158.17M	170.73M	118.31M	104.41M	82.9M	64.9M	57.4M
SG&A % of Revenue	-	39.69%	32.64%	31.01%	28.75%	27.48%	27.14%	28.38%	26.52%	25.33%	25.51%	26.43%	29.67%	28.04%	28.68%	28.7%	30.29%	29.17%	30.24%	31.84%	32.91%	33.1%	29.66%	27.68%	34.47%	37.84%	32.74%	34.86%	28.15%	26.16%	26.95%
Research & Development	0	54M	53.9M	56.5M	47.8M	54M	53.4M	17.8M	13M	13.5M	11.8M	10M	7.4M	2.87M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	3.02%	2.83%	2.82%	2.31%	2.43%	2.54%	1.04%	0.83%	0.91%	0.84%	0.72%	0.51%	0.22%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	2M	-54M	95.11M	9.84M	43.86M	15.6M	22.7M	53.91M	13.89M	54.05M	35.49M	29.83M	1.6M	27.41M	0	0	0	0	0	0	0	0	0	0	0	0	0	6.92M	5M	4M	2.7M
Operating Income	103.12M	106.78M	142.75M	260.59M	211.79M	272.55M	281.49M	178.25M	199.38M	169.06M	169.66M	116.29M	161.72M	117.1M	148.77M	139.39M	111.74M	89.37M	67.06M	73.92M	70.42M	71.38M	102.02M	85.77M	52.86M	41.66M	22.56M	9.42M	36.3M	30.1M	22.7M
Operating Margin %	5.65%	5.98%	7.48%	13%	10.22%	12.26%	13.41%	10.44%	12.75%	11.43%	12.14%	8.35%	11.19%	8.89%	11.55%	11.8%	14.38%	13.8%	10.77%	11.33%	11.09%	12.1%	17.54%	18.06%	11.52%	9.23%	6.24%	3.14%	12.33%	12.13%	10.66%
Operating Income Growth %	-	-25.19%	-45.22%	23.04%	-22.29%	-3.18%	57.92%	-10.6%	17.93%	-0.35%	45.89%	-28.09%	38.1%	-21.29%	6.73%	24.74%	25.04%	33.27%	-9.29%	4.98%	-1.35%	-30.04%	18.95%	62.27%	26.89%	84.63%	139.54%	-74.05%	20.6%	32.6%	30.46%
EBITDA	155.87M	160.08M	197.8M	312.09M	256.47M	308.38M	319.21M	215.66M	229.31M	202.79M	205.84M	151.18M	201.37M	150.94M	183.2M	169.56M	130.25M	104.63M	81.24M	88.22M	84.72M	83.81M	111.73M	91.9M	59.42M	50.29M	30.7M	16.34M	41.3M	34.1M	25.4M
EBITDA Margin %	8.54%	8.96%	10.37%	15.57%	12.37%	13.87%	15.21%	12.63%	14.66%	13.71%	14.73%	10.86%	13.93%	11.46%	14.22%	14.35%	16.76%	16.16%	13.05%	13.52%	13.34%	14.21%	19.21%	19.35%	12.95%	11.14%	8.49%	5.46%	14.02%	13.74%	11.92%
EBITDA Growth %	126.36%	-19.07%	-36.62%	21.68%	-16.83%	-3.39%	48.01%	-5.95%	13.07%	-1.48%	36.15%	-24.92%	33.41%	-17.61%	8.04%	30.19%	24.48%	28.79%	-7.91%	4.14%	1.09%	-24.99%	21.58%	54.67%	18.16%	63.81%	87.88%	-60.44%	21.11%	34.25%	29.59%
D&A (Non-Cash Add-back)	52.75M	53.3M	55.05M	51.5M	44.68M	35.83M	37.72M	37.41M	29.93M	33.73M	36.17M	34.89M	39.65M	33.84M	34.42M	30.18M	18.5M	15.26M	14.19M	14.3M	14.3M	12.43M	9.71M	6.13M	6.56M	8.63M	8.14M	6.92M	5M	4M	2.7M
EBIT	26.35M	-781.1M	213.56M	249.82M	242.25M	275.05M	290.89M	220.36M	201.66M	193.06M	173.53M	146.13M	170.72M	147.38M	148.77M	133.76M	105.9M	83.57M	-37.78M	76.3M	70.42M	71.38M	102.02M	85.77M	52.86M	41.66M	30.7M	9.42M	36.33M	30.1M	22.7M
Net Interest Income	-51.92M	-57.74M	-51.92M	-53.06M	-40.75M	-12.84M	-12.62M	-12.71M	-11.72M	-13.97M	-14.45M	-10.59M	-15.02M	-10.19M	-9.69M	-8.49M	-3.7M	-3.8M	-13.69M	-15.03M	0	0	0	0	0	0	0	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0	0	504K	0	0	70K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	51.92M	57.74M	51.92M	53.06M	40.75M	12.84M	12.62M	12.71M	11.72M	13.95M	14.86M	11.1M	15.02M	10.19M	9.76M	12.92M	9.69M	10.31M	13.69M	15.03M	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	-129.62M	-945.62M	-51.08M	-51.55M	-40.5M	-12.58M	-12.06M	-12.31M	-11.38M	-13.62M	-13.95M	-10.28M	-14.51M	-9.97M	-13.26M	-13.29M	-9.12M	-9.26M	-11.25M	-12.65M	-15.27M	-15.58M	-12.45M	265K	-2.11M	-3.11M	-1.67M	3.68M	-919K	-1.28M	-500K
Pretax Income	-26.5M	-838.84M	91.66M	209.04M	171.29M	259.97M	269.43M	165.94M	188M	155.44M	155.72M	106.01M	147.21M	107.13M	135.51M	126.09M	102.63M	80.11M	-51.47M	61.27M	55.15M	55.8M	89.58M	86.04M	50.75M	38.55M	20.89M	13.1M	35.4M	28.8M	22.2M
Pretax Margin %	-1.45%	-46.96%	4.81%	10.43%	8.26%	11.69%	12.84%	9.72%	12.02%	10.51%	11.14%	7.61%	10.19%	8.13%	10.52%	10.67%	13.21%	12.37%	-8.26%	9.39%	8.69%	9.46%	15.4%	18.12%	11.06%	8.54%	5.78%	4.37%	12.02%	11.61%	10.42%
Income Tax	72.73M	60.14M	-32.09M	40.45M	28.02M	36.2M	15.48M	13.61M	13.78M	26.56M	9.2M	18.59M	16.05M	20.89M	19.85M	15.72M	9.32M	8.29M	5.33M	-236K	5.06M	6.49M	12.91M	14.48M	12.03M	9.33M	3.56M	-14K	7.1M	6.5M	5M
Effective Tax Rate %	-274.46%	-7.17%	-35.01%	19.35%	16.36%	13.93%	5.75%	8.2%	7.33%	17.08%	5.91%	17.54%	10.9%	19.5%	14.65%	12.47%	9.08%	10.35%	-10.35%	-0.39%	9.18%	11.63%	14.41%	16.83%	23.71%	24.21%	17.03%	-0.11%	20.06%	22.57%	22.52%
Net Income	-99.23M	-898.98M	123.75M	168.59M	143.27M	223.76M	253.95M	152.33M	168.54M	44.45M	140.69M	101.23M	131.16M	86.25M	115.67M	110.37M	93.31M	71.82M	-56.79M	61.51M	50.09M	49.31M	76.45M	60.52M	38.72M	29.21M	17.33M	13.11M	28.3M	22.3M	17.2M
Net Margin %	-5.43%	-50.33%	6.49%	8.41%	6.91%	10.06%	12.1%	8.92%	10.78%	3.01%	10.07%	7.27%	9.08%	6.55%	8.98%	9.34%	12.01%	11.09%	-9.12%	9.43%	7.89%	8.36%	13.15%	12.75%	8.44%	6.47%	4.8%	4.38%	9.61%	8.99%	8.08%
Net Income Growth %	84.94%	-826.44%	-26.6%	17.67%	-35.97%	-11.89%	66.7%	-9.62%	279.21%	-68.41%	38.98%	-22.82%	52.08%	-25.43%	4.79%	18.29%	29.92%	226.45%	-192.33%	22.8%	1.58%	-35.5%	26.32%	56.32%	32.52%	68.56%	32.19%	-53.67%	26.91%	29.65%	31.3%
Net Income (Continuing)	-99.23M	-898.98M	123.75M	168.59M	143.27M	223.76M	253.95M	152.33M	174.22M	128.88M	144.31M	92.99M	131.16M	86.25M	115.67M	110.37M	93.31M	71.82M	-56.79M	61.51M	50.09M	49.31M	76.67M	71.56M	38.72M	29.21M	17.33M	13.11M	28.33M	22.33M	17.2M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	8.24M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-4.11	-39.08	5.37	7.03	5.95	9.17	10.08	6.02	6.62	4.73	5.17	3.23	4.52	2.66	3.62	3.48	2.98	2.32	-1.88	1.93	1.58	1.56	2.35	1.94	1.31	1.00	0.60	0.44	0.96	0.77	0.62
EPS Growth %	84.81%	-827.75%	-23.61%	18.15%	-35.11%	-9.03%	67.44%	-9.06%	39.96%	-8.51%	60.06%	-28.54%	69.92%	-26.52%	4.02%	16.78%	28.45%	223.4%	-197.41%	22.15%	1.28%	-33.62%	21.13%	48.09%	31%	66.67%	36.36%	-54.17%	24.68%	24.19%	26.53%
EPS (Basic)	-	-39.08	5.38	7.03	5.98	9.27	10.16	6.06	6.68	5.47	5.24	3.29	4.59	2.69	3.64	3.52	3.04	2.38	-1.88	2.01	1.66	1.65	2.57	2.13	1.37	1.04	0.61	0.45	1.00	0.83	0.66
Diluted Shares Outstanding	24.15M	23M	23.07M	23.97M	24.09M	24.41M	25.2M	25.32M	26.3M	27.25M	27.89M	28.75M	29.04M	32.39M	31.94M	31.7M	31.36M	30.92M	30.17M	31.8M	31.72M	31.61M	32.59M	31.26M	29.55M	29.2M	28.73M	29.89M	29.6M	28.85M	27.74M
Basic Shares Outstanding	23.3M	23M	23.04M	23.97M	24.08M	24.4M	25.19M	25.32M	25.46M	23.56M	27.21M	31.34M	29.02M	32.42M	31.95M	31.34M	30.67M	30.22M	30.17M	30.53M	30.12M	29.92M	29.71M	28.36M	28.19M	28.09M	28.42M	29.05M	28.28M	26.86M	26.06M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Metrics

Growth RegimeMixed

ProfitabilityStrained

Balance SheetStrained

Cash FlowMixed

Top Statement Risk

Impairment recurrence from licensed brand write-downs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q2)

Revenue Finds Traction After Two-Year Slide

After eight consecutive quarters of year-over-year revenue decline, Helen of Troy posted positive growth of 8.2% in 2027Q1 and 2.1% in 2027Q2, suggesting demand may be stabilizing; however, TTM revenue of approximately $1.79B still represents a 6.4% contraction, per recent SEC filings.

The return to positive top-line growth after sustained contraction suggests the portfolio may be approaching a trough, but the deceleration from 8.2% to 2.1% between consecutive quarters warrants scrutiny. Given that Home & Outdoor spending is discretionary and Health & Wellness volume is tied to flu season severity, the durability of this recovery remains uncertain. Investors should monitor whether growth persists through a full seasonal cycle before treating it as a durable inflection.

Gross Margin Expansion Masks SG&A Volatility

Helen of Troy's gross margin expanded to 52.2% in 2027Q2, the highest level across the ten-quarter window, yet operating margin compressed to 5.2% as SG&A surged to $204.7M, indicating pricing or mix gains are not translating through to profitability, as reported in company financial statements.

The gross margin trajectory suggests the premium positioning of OXO and Hydro Flask is holding, with the 52.2% print likely reflecting favorable input costs and favorable product mix. However, the sharp quarter-over-quarter swing in SG&A from $124.5M to $204.7M—a 64% increase—introduces significant opacity into underlying operating performance. For margin durability, the key question is whether SG&A stabilizes near the $170-185M range observed in most prior quarters or represents a new structural baseline.

Impairment Charges Define FY2026 Collapse

The 2026Q1 and 2026Q2 quarters represent the critical inflection point, with operating losses of $407.0M and $315.7M respectively on gross profit of only $175M and $190.7M, strongly suggesting large non-cash impairment charges that likely revalued goodwill or intangible assets, as reported in company filings.

The magnitude of these losses far exceeds what SG&A alone ($169.4M and $177.0M respectively) could explain, pointing to concentrated write-downs likely tied to the Health & Wellness or Beauty segments where licensed brand valuations may have deteriorated. The lasting impact is a materially eroded equity base, which has mechanically amplified reported ROE to -72.5% and appears to have constrained the balance sheet's capacity for further acquisition-driven growth. This inflection may permanently reset market expectations for Helen of Troy's house-of-brands model.

Reported Losses Mask Operating Recovery

The -50.33% TTM net margin contrasts sharply with a positive 5.98% operating margin, suggesting the reported net loss is dominated by non-operating items—likely impairment charges—rather than core deterioration, as evidenced by 2027Q1 returning to $35.8M in net income and $1.51 diluted EPS.

This divergence between operating and net profitability implies the underlying earnings power of the portfolio may be stronger than the headline loss suggests, but SBC volatility—ranging from $296K in 2026Q1 to -$14.7M in 2026Q4—introduces noise into any attempt to model true per-share economics. The absence of formal management guidance alongside the October 2026 earnings report further limits visibility into whether the impairment represents a one-time accounting reset or an ongoing valuation concern. Earnings quality would improve meaningfully if normalized tax rates and stable non-operating items can be demonstrated over the next two to three quarters.

Private Label Squeeze and Overhead Risk

SG&A consumption of 46.4% of revenue in 2027Q2 versus a 33-42% range in most prior quarters may indicate structural overhead expansion that could constrain operating leverage, particularly as private-label competitors exploit retailer data to erode OXO's premium positioning, an emerging risk warranting monitoring.

The strongest bear case centers on whether Helen of Troy's design-led differentiation can sustain its gross margin advantage as retailers like Amazon and Target build credible private-label alternatives in ergonomic housewares at 30-40% price discounts. Combined with reliance on licensed brands—Braun, Vicks, Honeywell—where renewal terms are not under the company's control, the risk of both margin erosion and revenue discontinuity appears potentially underappreciated. The debt-to-equity ratio of 1.04 against a materially compressed equity base further limits management's financial flexibility to absorb competitive shocks or pursue corrective acquisitions.

HELE — Frequently Asked Questions

Quick answers to the most common questions about buying HELE stock.

What was Helen of Troy Limited's (HELE) revenue in 2026?

For fiscal year 2026, Helen of Troy Limited (HELE) reported total revenue of $1.79B. This represents a 738.6% increase compared to $213.0M in 1997.

Is Helen of Troy Limited (HELE) profitable?

Helen of Troy Limited (HELE) reported a net loss of $899.0M for the fiscal year ending 2026.

What is Helen of Troy Limited's operating profit margin?

Helen of Troy Limited (HELE) reported an operating income of $106.8M, resulting in an operating profit margin of 6.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Helen of Troy Limited's gross profit and gross margin?

Helen of Troy Limited (HELE) generated $815.7M in gross profit for the year, representing a gross profit margin of 45.7%. This demonstrates the company's core pricing power and production efficiency.